Sugammadex Mylan Europska Unija - hrvatski - EMA (European Medicines Agency)

sugammadex mylan

mylan ireland limited - sugammadex sodium - neuromuskularna blokada - svi ostali terapeutski proizvodi - reversal of neuromuscular blockade induced by   rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.

Sugammadex Piramal Europska Unija - hrvatski - EMA (European Medicines Agency)

sugammadex piramal

piramal critical care b.v. - sugammadex sodium - neuromuskularna blokada - sugammadex - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults.

Sugammadex Amomed Europska Unija - hrvatski - EMA (European Medicines Agency)

sugammadex amomed

aop orphan pharmaceuticals gmbh - sugammadex sodium - neuromuskularna blokada - svi ostali terapeutski proizvodi - uklanjanje neuromuskularne blokade izazvane rokoronom ili vekuronomom. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.

Sugammadex Fresenius Kabi Europska Unija - hrvatski - EMA (European Medicines Agency)

sugammadex fresenius kabi

fresenius kabi deutschland gmbh - sugammadex sodium - neuromuskularna blokada - svi ostali terapeutski proizvodi - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.

Sugammadex Adroiq Europska Unija - hrvatski - EMA (European Medicines Agency)

sugammadex adroiq

extrovis eu ltd. - sugammadex sodium - neuromuskularna blokada - svi ostali terapeutski proizvodi - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.

Bridion Europska Unija - hrvatski - EMA (European Medicines Agency)

bridion

merck sharp & dohme b.v. - sugammadex - neuromuskularna blokada - svi ostali terapeutski proizvodi - uklanjanje neuromuskularne blokade izazvane rokoronom ili vekuronomom. za stanovništvo dječjem: сугаммадекс preporučuje se samo za obične preokret рокурония-induced blokade kod djece i adolescenata.

Sugamadeks Teva 100 mg/ml otopina za injekciju Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

sugamadeks teva 100 mg/ml otopina za injekciju

teva b.v., swensweg 5, haarlem, nizozemska - sugamadeksnatrij - otopina za injekciju - urbroj: 1 ml otopine sadrži 100 mg sugamadeksa (u obliku sugamadeksnatrija)

Sugamadeks Sandoz 100 mg/ml otopina za injekciju Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

sugamadeks sandoz 100 mg/ml otopina za injekciju

sandoz d.o.o., maksimirska 120, zagreb, hrvatska - sugamadeksnatrij - otopina za injekciju - 100 mg/ml - urbroj: 1 ml otopine sadrži 100 mg sugamadeksa (u obliku sugamadeksnatrija)

Sugamadeks Qilu 100 mg/ml otopina za injekciju Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

sugamadeks qilu 100 mg/ml otopina za injekciju

qilu pharma spain s.l., paseo de la castellana 40, planta 8, madrid, Španjolska - sugamadeksnatrij - otopina za injekciju - urbroj: 1 ml otopine sadrži 100 mg sugamadeksa (u obliku sugamadeksnatrija)

Sugamadeks AptaPharma 100 mg/ml otopina za injekciju Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

sugamadeks aptapharma 100 mg/ml otopina za injekciju

apta medica internacional d.o.o., likozarjeva ulica 6, ljubljana, slovenija - sugamadeksnatrij - otopina za injekciju - urbroj: 1 ml otopine sadrži 100 mg sugamadeksa (u obliku sugamadeksnatrija)